Efficacy and mechanism of action of sovleplenib for aplastic anemia
{{output}}
Objective: This study aimed to investigate the therapeutic potential of sovleplenib, a selective SYK inhibitor, in aplastic anemia (AA), focusing on its effects on immune modulation and the cGAS-STING-NF-κB inflammatory axis. ... ...
